{"count": 7, "results": [{"_id": "24673913", "pmid": 24673913, "pmcid": "PMC3976049", "title": "Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats", "journal": "Diabetol Metab Syndr", "authors": ["Singh B", "Sangle GV", "Murugan J", "Umrani R", "Roy S", "Kulkarni O", "Semwal A", "Unnikrishnan M", "Jain M"], "date": "2014-03-28T00:00:00Z", "doi": "10.1186/1758-5996-6-45", "meta_date_publication": "2014 Mar 28", "meta_volume": "6", "meta_issue": "1", "meta_pages": "45", "score": 50064.05, "text_hl": "...In combination, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-Amlodipine@@@ and @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@Pioglitazone@@@ significantly reduced @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ (115.1 +- 6.6 vs. 81.7 +- 4.2), BP (184.4 +- 5.0 vs. 155.1 +- 5.0), serum @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglycerides@@@ (362.5 +- 47.5 vs. 211.1 +- 23.7) and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@ when compared with vehicle treated Zucker fa/fa @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Singh B, Sangle GV, Murugan J, Umrani R, Roy S, Kulkarni O, Semwal A, Unnikrishnan M, Jain M. Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats Diabetol Metab Syndr. 2014 Mar 28;6(1):45. PMID: 24673913", "BibTeX": "@article{24673913, title={Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats}, author={Singh B and Sangle GV and Murugan J and Umrani R and Roy S and Kulkarni O and Semwal A and Unnikrishnan M and Jain M}, journal={Diabetol Metab Syndr}, volume={6}, number={1}, pages={45}}"}}, {"_id": "22232134", "pmid": 22232134, "title": "Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.", "journal": "Hypertension", "authors": ["Muramatsu T", "Matsushita K", "Yamashita K", "Kondo T", "Maeda K", "Shintani S", "Ichimiya S", "Ohno M", "Sone T", "Ikeda N", "Watarai M", "Murohara T", "NAGOYA HEART Study Investigators"], "date": "2012-03-01T00:00:00Z", "doi": "10.1161/HYPERTENSIONAHA.111.184226", "meta_date_publication": "2012 Mar", "meta_volume": "59", "meta_issue": "3", "meta_pages": "580-6", "score": 50061.9, "text_hl": "Comparison between @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ regarding cardiovascular morbidity and mortality in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@: NAGOYA @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@HEART@@@ Study.", "citations": {"NLM": "Muramatsu T, Matsushita K, Yamashita K, Kondo T, Maeda K, Shintani S, Ichimiya S, Ohno M, Sone T, Ikeda N, Watarai M, Murohara T, NAGOYA HEART Study Investigators. Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study. Hypertension. 2012 Mar;59(3):580-6. PMID: 22232134", "BibTeX": "@article{22232134, title={Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.}, author={Muramatsu T and Matsushita K and Yamashita K and Kondo T and Maeda K and Shintani S and Ichimiya S and Ohno M and Sone T and Ikeda N and Watarai M and Murohara T and NAGOYA HEART Study Investigators}, journal={Hypertension}, volume={59}, number={3}, pages={580-6}}"}}, {"_id": "27610083", "pmid": 27610083, "pmcid": "PMC4996984", "title": "Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-alpha in Hypertensive Patients with Prediabetes", "journal": "Front Aging Neurosci", "authors": ["Huang Z", "Chen C", "Li S", "Kong F", "Shan P", "Huang W"], "date": "2016-08-25T00:00:00Z", "doi": "10.3389/fnagi.2016.00206", "meta_date_publication": "2016", "meta_volume": "8", "meta_issue": "", "meta_pages": "206", "score": 50060.637, "text_hl": "@DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@Prediabetes@@@ was diagnosed according to 2010 ADA criteria including @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ (@DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@IFG@@@) or/and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ (@<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@IGT@@@; American @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Association,) tests.", "citations": {"NLM": "Huang Z, Chen C, Li S, Kong F, Shan P, Huang W. Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-alpha in Hypertensive Patients with Prediabetes Front Aging Neurosci. 2016;8():206. PMID: 27610083", "BibTeX": "@article{27610083, title={Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-alpha in Hypertensive Patients with Prediabetes}, author={Huang Z and Chen C and Li S and Kong F and Shan P and Huang W}, journal={Front Aging Neurosci}, volume={8}, pages={206}}"}}, {"_id": "20409690", "pmid": 20409690, "title": "Rationale and design of the NAGOYA HEART Study: comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance.", "journal": "J Cardiol", "authors": ["Matsushita K", "Muramatsu T", "Kondo T", "Maeda K", "Shintani S", "Murohara T", "NAGOYA HEART Study Group"], "date": "2010-07-01T00:00:00Z", "doi": "10.1016/j.jjcc.2010.03.004", "meta_date_publication": "2010 Jul", "meta_volume": "56", "meta_issue": "1", "meta_pages": "111-7", "score": 50058.54, "text_hl": "Rationale and design of the NAGOYA @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@HEART@@@ Study: comparison between @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ regarding morbidity and mortality in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@.", "citations": {"NLM": "Matsushita K, Muramatsu T, Kondo T, Maeda K, Shintani S, Murohara T, NAGOYA HEART Study Group. Rationale and design of the NAGOYA HEART Study: comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance. J Cardiol. 2010 Jul;56(1):111-7. PMID: 20409690", "BibTeX": "@article{20409690, title={Rationale and design of the NAGOYA HEART Study: comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance.}, author={Matsushita K and Muramatsu T and Kondo T and Maeda K and Shintani S and Murohara T and NAGOYA HEART Study Group}, journal={J Cardiol}, volume={56}, number={1}, pages={111-7}}"}}, {"_id": "15013337", "pmid": 15013337, "title": "Angiotension converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats.", "journal": "Transplant Proc", "authors": ["Yavuz DG", "Tuğlular S", "Koçak H", "Atakan A", "Ozener C", "Akoğlu E", "Akalin S"], "date": "2004-01-01T00:00:00Z", "doi": "10.1016/j.transproceed.2003.11.038", "meta_date_publication": "2004 Jan-Feb", "meta_volume": "36", "meta_issue": "1", "meta_pages": "171-4", "score": 50056.45, "text_hl": "In summary, @CHEMICAL_Cyclosporine @CHEMICAL_MESH:D016572 @@@CsA@@@ treated @SPECIES_10116 @@@rats@@@ show @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@, which is improved by @CHEMICAL_Quinapril @CHEMICAL_MESH:D000077583 @@@quinapril@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ treatment. ", "citations": {"NLM": "Yavuz DG, Tuğlular S, Koçak H, Atakan A, Ozener C, Akoğlu E, Akalin S. Angiotension converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats. Transplant Proc. 2004 Jan-Feb;36(1):171-4. PMID: 15013337", "BibTeX": "@article{15013337, title={Angiotension converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats.}, author={Yavuz DG and Tuğlular S and Koçak H and Atakan A and Ozener C and Akoğlu E and Akalin S}, journal={Transplant Proc}, volume={36}, number={1}, pages={171-4}}"}}, {"_id": "19192538", "pmid": 19192538, "title": "[Investigation into vegetative regulation of blood circulation during 7-day dry immersion].", "journal": "Aviakosm Ekolog Med", "authors": ["Eshmanova AK", "Luchinskaia ES", "Baevskiĭ RM"], "date": "2008-09-01T00:00:00Z", "meta_date_publication": "2008 Sep-Oct", "meta_volume": "42", "meta_issue": "5", "meta_pages": "45-51", "score": 50056.43, "text_hl": "Presumably, it was the cause of @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@poor orthostatic tolerance@@@ of several test-subjects.", "citations": {"NLM": "Eshmanova AK, Luchinskaia ES, Baevskiĭ RM. [Investigation into vegetative regulation of blood circulation during 7-day dry immersion]. Aviakosm Ekolog Med. 2008 Sep-Oct;42(5):45-51. PMID: 19192538", "BibTeX": "@article{19192538, title={[Investigation into vegetative regulation of blood circulation during 7-day dry immersion].}, author={Eshmanova AK and Luchinskaia ES and Baevskiĭ RM}, journal={Aviakosm Ekolog Med}, volume={42}, number={5}, pages={45-51}}"}}, {"_id": "25927094", "pmid": 25927094, "title": "Corrigendum.", "journal": "J Cardiol", "date": "2015-03-01T00:00:00Z", "meta_date_publication": "2015 Mar", "meta_volume": "65", "meta_issue": "3", "meta_pages": "259", "score": 50048.51, "text_hl": "Corrigendum to \"Rationale and design of the NAGOYA @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@HEART@@@ Study: Comparison between @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ regarding morbidity and mortality in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@\" [J. ", "citations": {"NLM": "Corrigendum. J Cardiol. 2015 Mar;65(3):259. PMID: 25927094", "BibTeX": "@article{25927094, title={Corrigendum.}, journal={J Cardiol}, volume={65}, number={3}, pages={259}}"}}]}